-
Solid, heat-resistant vaccine to ease immunisation processes
EU researchers have set out to substitute liquid and freeze-dried vaccines for new, solid state candidates. If successful, the research will enable the large scale production of new virosome-based vaccines with increased stability, longer shelf life and less invasive administration methods.
- Categories
- Health Care
-
Campaign Launched to Cut Price of Penumonia Vaccine
A global campaign is calling on GlaxoSmithKline (GSK) and Pfizer to slash the price of the pneumonia vaccine in developing countries to $5 or less per child.
- Categories
- Health Care
-
PRESS RELEASE: Global vaccination targets ‘off-track,’ warns WHO
Progress towards global vaccination targets for 2015 is far off-track with 1 in 5 children still missing out on routine life-saving immunizations that could avert 1.5 million deaths each year from preventable diseases.
- Categories
- Health Care
-
Twitter Top Ten – 3/15/15
In a typical week, the Twitter machine produces about 3.5 billion tweets. Some of them actually contain useful information ... like the ones in our weekly Twitter Top 10.
- Categories
- Entrepreneurship, Health Care, NextBillion Originals
-
Vaccines Are Profitable, So What?
By now, the numbers on the recent U.S. measles outbreak are well known. In 2014, America had more than 600 cases of measles—the highest number in 20 years. In the month of January 2015 alone, 84 people in 14 states reported having measles, with most cases linked to an incident at Disneyland. The reason for the resurgence? More and more people are opting to not vaccinate their kids.
- Categories
- Health Care
-
Ebola Vaccine Trial in Africa May Support More Potent Version
An experimental Ebola vaccine showed it was safe and generated an immune response in healthy Ugandan adults in a clinical trial that bodes well for a more potent version undergoing testing.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Gates Foundation Donates $4.9m to SK Chemicals’ Vaccine Project
SK Chemicals Co., a petrochemical unit of South Korea's third-largest conglomerate SK Group, said Sunday it has received a donation of US$4.9 million from the Bill & Melinda Gates Foundation for its project to develop a vaccine for typhoid fever.
- Categories
- Health Care
- Region
- Asia Pacific
-
Incentive Program May Alter the Economics of Ebola Vaccines
Earlier this week, U.S. President Barack Obama signed into law a little piece of legislation that may significantly change the economics of making drugs or vaccines to protect against Ebola and other viruses in its deadly family.
- Categories
- Health Care
Parent Organization
